LUMATE-AT Dry Syp.
MRP: 170
Packaging: 30ml
Pack Type: syrup
Composition:
Artemether 40mg + Lumefantrine 240mg (with WFI)
Indication:
Provides quick control on the symptoms of Malaria
Description:
Artemether and Lumefantrine is a powerful antimalarial combination therapy used for the treatment of uncomplicated Plasmodium falciparum malaria, including infections acquired in chloroquine-resistant areas. Artemether acts quickly on the malaria parasite, while Lumefantrine provides a sustained antimalarial effect, preventing recurrence.
Tags:
- Rapid parasite clearance due to fast action of Artemether
- Sustained antimalarial action by Lumefantrine prevents relapse
- Effective against multidrug-resistant Plasmodium falciparum
- Short treatment duration
- Suitable for both adults and children under medical supervision
Usage Information
Dosage
Adults & Children: Dosage as per body weight, prescribed by physician Route: Intramuscular or intravenous (based on clinical need) Form: Injection with WFI (Water for Injection) as diluent Always administer under the supervision of a healthcare professional.
Side Effects
Headache, dizziness Nausea, vomiting Muscle or joint pain Rare: QT prolongation (heart rhythm issue), especially in overdose
Contraindications
Known hypersensitivity to Artemether, Lumefantrine, or related compounds Severe cardiac conditions (QT interval prolongation) Patients on medications that prolong QT interval (consult physician) Use with caution in pregnant women and infants under 5 kg (unless prescribed)